在最初诊断时,头癌与远程转移的治疗结果
Jo Omata1, Yushi Ueki1, Yuto Takahashi1
1Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
The Laryngoscope
|September 12, 2023
概括
结合免疫检查点抑制剂 (ICI) 与放射治疗 (RT) 或手术的强化治疗改善了诊断时患有远程转移的头部和部状细胞癌 (HNSCC) 患者的生存率.
科学领域:
- 在瘤学瘤学.
- 头部和部癌症研究研究
背景情况:
- 复发性/转移性头角状细胞癌 (HNSCC) 治疗已经通过免疫检查点抑制剂 (ICI) 进化.
- 在初始诊断时存在远程转移 (M1) 的HNSCC数据有限,缺乏标准化的治疗策略.
研究的目的:
- 分析治疗结果,并确定诊断初始M1疾病的HNSCC患者的预后因素.
主要方法:
- 一项多机构追溯研究,对98名初始M1疾病的HNSCC患者进行了多机构追溯研究 (2007-2021).
- 患者被分为非息性 (全身化疗,n=60) 和息性 (没有化疗,n=38) 组.
- 总体生存率 (OS) 进行了比较,在非息治疗组中探索了OS的预测因素.
主要成果:
- 与息治疗组 (3个月) 相比,非息治疗组 (15个月) 的中位 OS 显著更长 (p < 0.001).
- 改善OS的独立预后因素包括局部区域辐射疗法 (RT) (HR 0.407),ICI (HR 0.216) 和远程转移的RT/手术 (HR 0.373).
结论:
- 综合系统治疗与ICI和RT/手术用于局部或远程转移的密集治疗策略可以改善初始M1疾病的HNSCC患者的生存率.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.3K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
